SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15932366
Source:
http://linkedlifedata.com/resource/pubmed/id/15932366
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0014268
,
umls-concept:C0087111
,
umls-concept:C0127615
,
umls-concept:C0205195
,
umls-concept:C0375359
,
umls-concept:C0442027
,
umls-concept:C1420702
pubmed:issue
11
pubmed:dateCreated
2005-6-3
pubmed:abstractText
Current treatment of ulcerative colitis is imperfect. Trefoil peptides are known to stimulate repair in many models of injury, including animal models of colitis.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Mesalamine
,
http://linkedlifedata.com/resource/pubmed/chemical/Mucins
,
http://linkedlifedata.com/resource/pubmed/chemical/Muscle Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/TFF3 protein, human
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0269-2813
pubmed:author
pubmed-author:FitzgeraldA JAJ
,
pubmed-author:GhoshSS
,
pubmed-author:MahmoodAA
,
pubmed-author:MellerEE
,
pubmed-author:PlayfordR JRJ
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1357-64
pubmed:dateRevised
2007-8-13
pubmed:meshHeading
pubmed-meshheading:15932366-Administration, Oral
,
pubmed-meshheading:15932366-Adult
,
pubmed-meshheading:15932366-Colitis, Ulcerative
,
pubmed-meshheading:15932366-Double-Blind Method
,
pubmed-meshheading:15932366-Drug Therapy, Combination
,
pubmed-meshheading:15932366-Enema
,
pubmed-meshheading:15932366-Female
,
pubmed-meshheading:15932366-Humans
,
pubmed-meshheading:15932366-Male
,
pubmed-meshheading:15932366-Mesalamine
,
pubmed-meshheading:15932366-Middle Aged
,
pubmed-meshheading:15932366-Mucins
,
pubmed-meshheading:15932366-Muscle Proteins
,
pubmed-meshheading:15932366-Patient Compliance
,
pubmed-meshheading:15932366-Peptides
,
pubmed-meshheading:15932366-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis.
pubmed:affiliation
Department of Gastroenterology, Imperial College, Hammersmith Hospital Campus, London, UK.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II
,
Clinical Trial, Phase I